✦ LIBER ✦

Escitalopram in the treatment of social anxiety disorder: Analysis of efficacy for different clinical subgroups and symptom dimensions

✍ Scribed by Dan J. Stein; Siegfried Kasper; Elisabeth Wreford Andersen; Rico Nil; Malcolm Lader

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 97 KB
Volume: 20
Category: Article
ISSN: 1091-4269
DOI: 10.1002/da.20043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of duloxetine in the treatment

Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms

✍ James M. Russell; Risa Weisberg; Maurizio Fava; James T. Hartford; Janelle S. Er 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB 👁 2 views

Efficacy and tolerability of escitalopra

Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study

✍ Malcolm Lader; Karina Stender; Vera Bürger; Rico Nil 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

How long should a trial of escitalopram

How long should a trial of escitalopram treatment be in patients with major depressive disorder, generalised anxiety disorder or social anxiety disorder? An exploration of the randomised controlled trial database

✍ David S. Baldwin; Dan J. Stein; Ornah T. Dolberg; Borwin Bandelow 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

## Abstract ## Objective To extend the knowledge of course of improvement in patients with major depressive disorder (MDD), social anxiety disorder (SAD) or generalised anxiety disorder (GAD) participating in randomised placebo‐controlled trials (RCTs) and to infer the optimal duration of initial